Literature DB >> 1350070

Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study.

M Beauregard1, A Ferron, L Descarries.   

Abstract

Anatomical, biochemical and behavioral data suggest functional interactions between dopamine and neurotensin in regions of the brain receiving a co-existent and/or distinct innervation by these two transmitters. We therefore measured and compared the effects of iontophoretically applied dopamine and neurotensin in the prefrontal and anterior cingulate cortex (co-existent innervation) vs the nucleus accumbens and neostriatum (distinct innervation) of urethane-anesthetized rats. In every region, the firing rate of most spontaneously active neurons was depressed by dopamine. Neurotensin had no effect on the same cells, except for a few nucleus accumbens units which were inhibited by the peptide. When dopamine and neurotensin were concomitantly applied, the magnitude of maximal inhibitions induced by dopamine was modified in the majority of neurons tested. A significant decrease in dopamine inhibition was observed in 100% of anterior cingulate, 74% of prefrontal cortex and 48% of accumbens units. On the contrary, in neostriatum, dopamine inhibition was significantly increased in 60% of the units tested. In every region, the remaining neurons showed less than 30% changes in dopamine responsiveness, and were therefore considered unaffected by neurotensin. In the anterior cingulate cortex, inhibitions, respectively, induced by the dopamine D1 agonist, SKF 38393, and the D2 agonist, LY 171555, were also decreased by simultaneous application of neurotensin. Together with currently available data on the cellular localization of neurotensin receptors in rat brain, these results suggest that the modulation of dopamine inhibition by neurotensin may have opposite effects depending on whether the neurotensin receptors are located postsynaptically on target neurons (antagonistic effects) or presynaptically on dopamine terminals (potentiating effects).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350070     DOI: 10.1016/0306-4522(92)90170-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Clozapine administration modifies neurotensin effect on synaptosomal membrane Na+, K+ -ATPase activity.

Authors:  María G López Ordieres; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

2.  Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist.

Authors:  Vanessa Lopak; Suzanne Erb
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.

Authors:  Yanqi Liang; Mona Boules; Zhimin Li; Katrina Williams; Tomofumi Miura; Alfredo Oliveros; Elliott Richelson
Journal:  Neuropharmacology       Date:  2010-03-06       Impact factor: 5.250

4.  Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.

Authors:  Dominic Thibault; Paul R Albert; Graciela Pineyro; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

5.  Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens.

Authors:  K Ikemoto; K Satoh; K Kitahama; M Geffard; T Maeda
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

6.  Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.

Authors:  A M Alam; M S Starr
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists.

Authors:  M Poncelet; C Gueudet; D Gully; P Soubrié; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

8.  Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin.

Authors:  Khalil Rouibi; Poulomee Bose; Pierre-Paul Rompré; Richard A Warren
Journal:  Front Neurosci       Date:  2015-12-22       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.